Starting With the Practical Question
For many patients who contact KetaMed Infusion Center, the question is not simply whether ketamine belongs in their care. It is more immediate than that. They want to understand what treatment would actually ask of them on an ordinary Tuesday.
Would they come to our Salisbury office? Would they need someone to drive them? Could treatment fit around work, caregiving, or the distance between home and the Eastern Shore?
Those are important questions. They are also different from asking which option is universally better. There is no single answer that fits every person.
We offer both IM ketamine therapy and prescribed ketamine troches. Each has a distinct rhythm. One is structured around an in-clinic appointment and direct observation. The other is built around a home routine, clear preparation, and ongoing communication with our clinical team.
For psychiatric care, ketamine is used off-label. That means the Food and Drug Administration has not approved ketamine specifically for psychiatric conditions, even though clinicians may prescribe an approved medication for an off-label use when it is clinically appropriate. The evidence base around ketamine continues to develop, and expert guidance on implementation emphasizes thoughtful screening, monitoring, and follow-up (McIntyre et al., 2021).
The In-Clinic Structure of IM Ketamine
IM ketamine is administered by injection during a scheduled visit at our clinic. The appointment has a defined beginning, middle, and end. You arrive, meet with our team, receive the medication under clinical direction, and remain with us through the observation period.
That structure matters. It creates a protected window in the day, away from errands, household demands, and the impulse to return too quickly to normal activity. During the visit, we can observe how you are doing in real time and respond to concerns as they arise.
Ketamine can produce temporary perceptual changes, dissociation, nausea, changes in blood pressure, or emotional intensity. These experiences vary. Clinical research on ketamine and circulation helps explain why cardiovascular effects warrant clinical attention during care (Zielmann et al., 1997). A monitored clinical setting allows us to focus on your comfort and safety while the acute effects are present.
We also ask that you arrange transportation home after an IM appointment. Driving, operating machinery, making major decisions, or returning immediately to demanding responsibilities is not appropriate after treatment. The day needs room around it.
For patients comparing injection-based options, our discussion of IM and IV delivery may also be helpful. The conversation is not about ranking methods. It is about understanding what each format involves.
Ketamine Troches and the At-Home Routine
Ketamine troches are prescribed for use at home according to an individualized treatment plan. A troche dissolves in the mouth, which makes the practical experience very different from traveling to our Salisbury office for an appointment.
For some people, the at-home setting feels more familiar. For others, it requires more deliberate planning. Home treatment still needs a calm, private environment, time set aside from obligations, and a responsible approach to the instructions we provide.
A troche appointment may not look like a clinic appointment, but it should not become casual. We encourage patients to think ahead about a quiet space, a predictable time, and the absence of interruptions. Children, pets, phones, work messages, and household tasks can pull attention in several directions. Creating a simple routine can help protect the treatment window.
At-home treatment also means you carry more of the practical responsibility between visits. You need to follow dosing instructions precisely, store medication securely, avoid combining it with substances or medications unless our team has specifically discussed them with you, and tell us about meaningful changes in your health or symptoms. Medication review matters because ketamine metabolism involves hepatic CYP450 enzymes (Loan Nguyen et al., 2024).
Our fuller explanation of how at-home ketamine works addresses the preparation and communication that support this option.
Supervision Is Present in Different Ways
The clearest difference between IM ketamine and troches is the form supervision takes.
With IM ketamine, supervision is immediate and in person. We are physically present during the appointment. We monitor your experience, provide a clinical setting, and make sure you have recovered sufficiently before you leave with your arranged ride.
With troches, supervision is organized through prescribing, instructions, scheduled follow-up, and your communication with us between appointments. You are not alone in the larger treatment plan, but you are not sitting in our clinic while the medication takes effect.
Neither arrangement should be treated as an afterthought. They simply place different demands on your schedule, environment, and capacity for routine.
Research into ketamine’s psychiatric effects is still clarifying why some individuals respond differently than others. Studies of potential response biomarkers underscore that treatment response is biologically and clinically variable (Kadriu et al., 2020). That uncertainty is one reason we do not make decisions based on convenience alone.
Follow-Up Is Part of the Treatment, Not an Extra
Whether you receive IM ketamine or use troches at home, follow-up gives us a chance to understand the whole picture. We want to know more than whether a dose felt intense or mild.
We ask about changes in symptoms, sleep, daily functioning, mood, pain, side effects, medication changes, substance use, and anything else that may affect care. We also want to hear what happens between treatments. Sometimes the most useful information is not found in the hour after medication. It emerges in the days that follow.
Ketamine’s effects are being studied in relation to neural signaling and synaptic plasticity. Research on stress and synaptic change has helped shape scientific understanding of rapid-acting antidepressant pathways (Duman et al., 2016). But a biological explanation is not a substitute for careful clinical attention. Your treatment plan should account for your medical history, current care, and lived experience.
When appropriate, we may also encourage coordination with your psychiatrist, therapist, primary care clinician, or pain specialist. Ketamine can be one part of care. It does not need to carry the whole weight of your health alone.
Choosing a Format That Fits Your Life and Clinical Needs
Some patients begin with a clear preference. Others are unsure. Both are reasonable places to start.
During an evaluation, we consider practical questions alongside clinical ones:
Can you reliably travel to and from in-clinic appointments?
Do you have a safe, quiet home environment for a prescribed troche routine?
Is a support person available when needed?
What medications, health conditions, and treatment history need consideration?
How comfortable are you with the responsibilities of at-home treatment?
What follow-up structure will help us make informed decisions together?
We take your preferences seriously. Still, a preference is one part of the conversation, not the whole answer. Our initial ketamine evaluation is designed to give those details the attention they deserve.
For some patients, a particular option may not be appropriate at a given time. Additional records, medical coordination, stabilization, or another kind of support may be needed first. We explain that as directly as possible.
Frequently Asked Questions
Is IM ketamine stronger than ketamine troches?
These formats differ in how medication is administered and in the setting around treatment. We do not describe one as inherently stronger, safer, or more effective for every person. The relevant question is whether a particular format fits your clinical needs and treatment plan.
Do I need to bring someone with me for IM ketamine?
You should arrange a responsible adult to drive you home after an IM ketamine appointment. You should not drive after treatment.
Can I take ketamine troches whenever I have time?
No. Prescribed troches should be used only according to the schedule and instructions we establish with you. Set aside the needed time and avoid treating the dose as something to squeeze between obligations.
What if my symptoms worsen between follow-up visits?
Contact our team so we can discuss what is happening and what next steps may be appropriate. If you are in immediate danger, having thoughts of harming yourself, or unable to stay safe, call or text the 988 Suicide and Crisis Lifeline for 24/7 crisis support (988 Suicide and Crisis Lifeline, n.d.), call 911, or go to the nearest emergency department.
A Thoughtful Next Step in Salisbury
The choice between IM ketamine and ketamine troches is often a choice about structure. One brings you into a monitored clinical setting. The other asks you to create a reliable treatment environment at home. Both call for honesty, preparation, and follow-up.
We believe those details deserve a real conversation. If you are considering ketamine therapy for mental health or chronic pain, we invite you to schedule a consultation with our team in Salisbury. Together, we can discuss what care may fit your circumstances and what questions still need answering.
This content is for educational purposes only and does not replace individualized medical advice, diagnosis, or treatment from a qualified clinician. Treatment decisions require a personal clinical evaluation. If you are experiencing an emergency or cannot stay safe, call 911 or go to the nearest emergency department.
Works Cited
1. McIntyre RS, et al. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. https://pubmed.ncbi.nlm.nih.gov/33726522/
2. Zielmann S, et al. [S-(+)-Ketamine and circulation]. https://pubmed.ncbi.nlm.nih.gov/9163278/
3. Loan Nguyen TM, et al. Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions. https://pubmed.ncbi.nlm.nih.gov/39004413/
4. Kadriu B, et al. Neurobiological biomarkers of response to ketamine. https://pubmed.ncbi.nlm.nih.gov/32616207/
5. Duman RS, et al. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. https://pubmed.ncbi.nlm.nih.gov/26937618/
6. 988 Suicide and Crisis Lifeline. https://988lifeline.org/
Disclaimer
This article is for educational purposes only and is not a substitute for individualized evaluation, diagnosis, or treatment from a qualified healthcare professional.